Χαράλαμπος Μπακογιάννης ΠΑΘΟΛΟΓΟΣ - ΟΓΚΟΛΟΓΟΣ Αναπλ. Διευθυντής Β' Παθολογικής - Ογκολογικής Κλινικής

Εκπαίδευση & Ακαδημαϊκοί Τίτλοι

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA.
Ann Oncol. 2008 Jan;19(1):115-22
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). Kosmidis PA, Fountzilas G, Eleftheraki AG, Kalofonos HP, Pentheroudakis G, Skarlos D, Dimopoulos MA, Bafaloukos D, Pectasides D, Samantas E, Boukovinas J, Lambaki S, Katirtzoglou N, Bakogiannis C, Syrigos KN.
Ann Oncol. 2011 Apr;22(4):827-34
Treatment adherence of cancer patients to orally administered chemotherapy: insights from a Greek study using a self-reported questionnaire. Saratsiotou I, Kordoni M, Bakogiannis C, Livadarou E, Skarlos D, Kosmidis PA, Razis E.
J Oncol Pharm Pract. 2011 Dec;17(4):304-11
Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). Koutsoukos K, Tzannis K, Christodoulou C, Karavasilis V, Bakoyiannis C, Makatsoris T, Papandreou CN, Pectasides D, Dimopoulos MA, Bamias A. World J Urol. 2015 Sep 26. [Epub ahead of print]